New Horizon Health Closed US$ 20m in Series D Round
New Horizon Health is a leading Chinese molecular diagnostic company focusing on early cancer detection. VMS led its series C financing and participated in its series D financing. On product side, the Company has launched at-home cancer screening products for intestinal cancer, cervical cancer, gastric cancer and lung cancer.
Please browse the link below for more detail: